APA (7th ed.) Citation

Huang, X., Lv, X., & Cao, X. (2026). Identification of Prognosis Signature Based on cGAS-STING Pathway and Its Immunotherapeutic Significance in Lung Adenocarcinoma. Molecular Biotechnology, 68(1), 308. https://doi.org/10.1007/s12033-025-01376-x

Chicago Style (17th ed.) Citation

Huang, Xiao, Xuefeng Lv, and Xinghua Cao. "Identification of Prognosis Signature Based on CGAS-STING Pathway and Its Immunotherapeutic Significance in Lung Adenocarcinoma." Molecular Biotechnology 68, no. 1 (2026): 308. https://doi.org/10.1007/s12033-025-01376-x.

MLA (9th ed.) Citation

Huang, Xiao, et al. "Identification of Prognosis Signature Based on CGAS-STING Pathway and Its Immunotherapeutic Significance in Lung Adenocarcinoma." Molecular Biotechnology, vol. 68, no. 1, 2026, p. 308, https://doi.org/10.1007/s12033-025-01376-x.